Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies

NCT00670592

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +9 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • St. Francis Cancer Research Foundation Dept.ofSt.FrancisCancerRes.(2) Beech Grove, Indiana, United States
  • Dana Farber Cancer Institute SC-5 Boston, Massachusetts, United States
  • Wake Forest University Baptist Medical Center Dept. of Industry Research (2) Winston-Salem, North Carolina, United States
View all 28 locations
View Trial Details
Completed

Study of HCD122 (Lucatumumab) and Bendamustine Combination Therapy in CD40+ Rituximab-refractory Follicular Lymphoma

NCT01275209

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Dana Farber Cancer Institute SC-5 Boston, Massachusetts, United States
  • Wayne State University/Karmanos Cancer Institute Dept.of KarmanosCancerInst (6) Detroit, Michigan, United States
  • Duke University Medical Center Duke Hem & Onc Durham, North Carolina, United States
  • Sarah Cannon Research Institute SC - 2 Chattanooga, Tennessee, United States
View Trial Details
Completed

Study of Lymphoma in Asia

NCT01584141

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
Locations
  • Tianjin Medical University Cancer Institute & Hospital Hexi District, China
  • West China Hospital of Sichuan University Sichuan, China
  • Queen Mary Hospital Sai Ying Pun, Hong Kong
  • Buddhis Dalin Tzu Chi General Hospital Dalin Town, Taiwan
View Trial Details
Completed

Interdisciplinary Case-Control Study of Non-Hodgkin's Lymphoma

NCT00341952

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • University of Southern California Los Angeles, California, United States
  • University of Iowa Iowa City, Iowa, United States
  • Wayne State University Hutzel Hospital Detroit, Michigan, United States
  • University of Washington Seattle, Washington, United States
View Trial Details
Completed

Safety and Tolerability of BAY1862864 Injection in Subjects With Relapsed or Refractory CD22-positive Non-Hodgkin's Lymphoma

NCT02581878

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Skanes Universitetssjukhus Lund, Sweden
  • Southampton General Hospital Southampton, Hampshire, United Kingdom
  • Royal Marsden NHS Trust (Surrey) Sutton, Surrey, United Kingdom
  • Royal Free Hospital London, United Kingdom
View Trial Details

Related conditions